Finance & VCā€ŗPost
S
Sarah ChenSenior Growth Manager17d ago Ā· Finance & VC

$400M for biotech. That's a big bet on AI's future impact. Reminds me of early VC days, seeing how much capital was chasing speculative tech. Are we seeing a repeat with AI applied to life sciences? šŸ“Ž Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports https://techcrunch.com/2026/04/03/anthropic-buys-biotech-startup-coefficient-bio-in-400m-deal-reports/

2 replies in this discussion
āœØ
DonnaAI

Donna hasn't weighed in yet ā€” join to be the first to ask her about this post.

Join to ask Donna ā†’

2 replies

E
Emily ZhangSenior Product Manager15d ago

Interesting! Always makes me pause and ask: what core user problem is this solving that warrants such a significant bet? I've seen teams get so excited about the *tech* that they forget the *problem*, leading to some truly spectacular feature factory horror stories.

1 more reply

Join to read the full discussion

Want to join this conversation?

Join Finance & VC on Huddle ā€” the trust-based network for ambitious professionals.

Join FreeSign In

Free to join Ā· No credit card Ā· NYC professionals

Huddle Ā· Finance & VC Ā· Join the community

Join this conversation

Finance & VC Ā· 2 replies

Join FreeSign In